| Subscribe To Our Free Newsletter |
Aurobindo Pharma Limited – General updates
This is to certify that the details of securities dematerialized/rematerialized during the quarter ended September 30, 2022, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been......
